Ligand validation:3OD6

BOG: octyl beta-D-glucopyranoside

BOG is a Ligand Of Interest in 3OD6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OD6_BOG_X_1000	37%	33%	0.256	0.954	1.39	1.28	3	4	1	0	100%	1
8VT6_BOG_A_501	92%	50%	0.06	0.95	0.71	1.21	-	2	0	0	100%	1
3OEF_BOG_X_1000	87%	52%	0.071	0.944	1.24	0.65	2	-	0	0	100%	1
8VWM_BOG_A_403	87%	52%	0.067	0.938	0.63	1.2	-	3	2	0	100%	1
5ML5_BOG_A_402	84%	30%	0.096	0.957	0.92	1.84	2	6	0	0	100%	1
3HV5_BOG_B_1000	83%	43%	0.107	0.965	0.99	1.22	2	3	3	0	100%	1
4RWC_BOG_A_101	100%	75%	0.036	0.989	0.35	0.63	-	-	0	0	100%	1
6VL4_BOG_A_202	100%	67%	0.04	0.99	0.55	0.73	-	-	0	0	100%	1
2R4J_BOG_B_700	99%	50%	0.047	0.987	0.82	1.09	1	2	2	0	100%	1
5B5S_BOG_A_301	99%	45%	0.045	0.983	0.92	1.19	1	1	0	0	100%	1
4KRG_BOG_A_503	99%	54%	0.048	0.981	1.11	0.69	2	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.